WOUDENBERG MICHAEL 4
4 · InMed Pharmaceuticals Inc. · Filed Nov 15, 2022
Insider Transaction Report
Form 4
WOUDENBERG MICHAEL
VP, Chem/Manufacturing/Control
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-11-14+7,500→ 11,342 totalExercise: $2.78Exp: 2027-11-13→ Common shares (7,500 underlying)
Footnotes (2)
- [F1]The options were granted on 11/14/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant.
- [F2]On September 7, 2022, the common stock of InMed was reverse split on a 1-for-25 basis. This number reflects that reverse stock split.